Laboratory & Pathology Feature Articles
Victorian patients are one step closer to accessing medicinal cannabis with the Andrews Labor Government’s horticultural trial entering its second phase and a new Independent Medical ...
The Australian Burden of Disease Study: impact and causes of illness and death in Australia 2011- summary report was released on 5 August 2016 by the Australian Institute of Health ...
NSW Health is warning people to not consume rockmelon that is being recalled while an investigation into the source of a national outbreak of a rare strain of Salmonella is underway. ...
Health and consumer leaders have released a blueprint for 21st Century Medicare aimed at giving patients greater say in a team-based health care system.
In a landmark multi-country study, Australian researchers have transformed our understanding of the genes that affect our risk of cancer.
University of Queensland researchers are leading an international effort to slow the emergence of antimicrobial-resistant superbugs forecast to kill more people than cancer by 2050. ...
Doctors in NSW will now be able to apply to prescribe a broader range of cannabis- based medicines as a result of NSW Government regulatory changes.
Technological advances have brought about both advantages and disadvantages to those in medical practice.
A new strain of dengue virus discovered by Queensland scientists could help researchers evaluate the effectiveness of potential vaccines and treatments for the disease.
The Royal Australian College of General Practitioners has called for the Federal Government to quickly address plans to sustain and improve our health system, focusing specifically ...
General practice health services are among the most efficient and cost-effective in the nation, consuming only 7% of Australia's total health spend on Medicare while assisting almost ...
The latest Issues Brief from the Deeble Institute for Health Policy Research emphasises the need to urgently address the lack of reliable national primary health data, particularly ...
Recently, we covered the rise of telemedicine, a rapidly growing industry estimated to reach US $86.7 billion in 2023, growing from just $21.1 billion in 2014.
In an Australian first, NSW children with severe treatment-resistant epilepsy will be provided with compassionate access to Epidiolex® , a GW Pharmaceuticals cannabis-based medicine. ...
All options should be on table as we reconsider health funding that delivers affordable care with equity of access.
An innovative, whole-of-business program transforming pharmacies into a local health destination is delivering effective healthcare services and improving consumer engagement, ...
Australia’s Health Tracker was released 5 July 2016 by Australian Health Policy Collaboration (AHPC) at Victoria University and supported by 50 health and welfare organisations.
The absolute first priority for the incoming Government should be to end the extended freeze on the Medicare Benefits Schedule (MBS).
Though it raises a host of questions for regulators, providers, insurers and patients alike - telemedicine is here and it’s set to become mainstream, and fast!
The NSW Government continues to advance medical research in NSW through investment in the 2016-17 Budget.
Storefront Feature Articles